Status:
COMPLETED
Can Intrauterine Levonorgestrel Releasing Device Be a Treatment Option for Postmenstrual Spotting in Isthmocele
Lead Sponsor:
Gaziosmanpasa Research and Education Hospital
Conditions:
Isthmocele
Post-menstrual Spotting Bleeding
Eligibility:
FEMALE
30-40 years
Phase:
NA
Brief Summary
it was planned to investigate the treatment effect of levonorgestrel releasing intrauterine device in patient with isthmocele who were suffering from postmenstrual spotting bleeding and who had no des...
Detailed Description
isthmocele is an acquired diverticulum like defect of myometrium in the anterior isthmic part of uterus due to previous cesarean section incision. It can be defined as thinning of the incised site of ...
Eligibility Criteria
Inclusion
- having isthmocele and complaining for postmestrual spotting bleeding
- having cesarean section as a last delivery way.
- not planning for fertility
- complaining about dysmenorrhea and pelvic pain
Exclusion
- having pelvic infection
- having an any type of previous pelvic surgery
- having leiomyoma, endometrial polyp or adnexal mass
- having any type of malignancy
- having thyroid dysfunction and prolactinemia
Key Trial Info
Start Date :
November 3 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 12 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04872244
Start Date
November 3 2019
End Date
July 12 2021
Last Update
August 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
saglik Bilimleri Univercity Gaziosmanpaşa Training and Research Hospital
Istanbul, Turkey (Türkiye), 34245